Global Drug Delivery Devices Market By Product Type (Biocides & Disinfectants, Personal Protective Equipment (PPE), Detection & Monitoring Equipment, Decontamination Systems, and Others), by Application (Agriculture, Healthcare, Food Industry, Defense & Military, and Others), By End-User (Government & Regulatory Bodies, Healthcare Institutions, Agricultural Sector, Research & Academia, and Private & Commercial Sectors), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: July 2025
- Report ID: 19228
- Number of Pages: 275
- Format:
-
-
Table of Contents
- 1. Executive Summary
- 1.1. Definition
- 1.2. Market Snapshot
- 1.3. Market Overview
- 1.4. Segment Overview
- 1.5. Regional Overview
- 1.6. Competitive Landscape
- 1.7. Taxonomy
- 1.8. Industry Voices
- 2. Global Market Overview
- 2.1. Global Market Insights and Industry Overview
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunities
- 2.2.4. Key Drug Delivery Devices Market Trends
- 2.3. Technology Landscape
- 2.4. Regulatory Framework
- 2.5. Sustainability and ESG (Environmental, Social, Governance)
- 2.6. Opportunity Map Analysis
- 2.7. Opportunity Orbits
- 2.8. PESTLE Analysis
- 2.9. PORTER’S Five Force Analysis
- 2.10. Drivers & Restraints Impact Analysis
- 2.11. Value Chain Analysis
- 2.11.1. List of Raw Materials Suppliers
- 2.11.2. List of Drug Delivery Devices Manufacturers
- 2.11.3. List of Dealer/Distributors
- 2.12. Regional Market Share and BPS Analysis
- 2.13. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Drug Delivery Devices Market Analysis and Forecast, By Segment, 2020-2034
- 3.1. Key Findings
- 3.2. Global Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
- 3.3. Global Drug Delivery Devices Market Attractiveness Analysis, By Product
- 3.3.1. Inhalers
- 3.3.1.1. Insights
- 3.3.1.2. Key Takeaways
- 3.3.2. Injection Devices
- 3.3.2.1. Insights
- 3.3.2.2. Key Takeaways
- 3.3.3. Implants
- 3.3.3.1. Insights
- 3.3.3.2. Key Takeaways
- 3.3.4. Contraceptive implants
- 3.3.4.1. Insights
- 3.3.4.2. Key Takeaways
- 3.3.5. Drug-eluting stents
- 3.3.5.1. Insights
- 3.3.5.2. Key Takeaways
- 3.3.6. Biodegradable implants
- 3.3.6.1. Insights
- 3.3.6.2. Key Takeaways
- 3.3.7. Topical Delivery System
- 3.3.7.1. Insights
- 3.3.7.2. Key Takeaways
- 3.3.8. Oral Delivery System
- 3.3.8.1. Insights
- 3.3.8.2. Key Takeaways
- 3.3.9. Occular Delivery System
- 3.3.9.1. Insights
- 3.3.9.2. Key Takeaways
- 3.3.10. Nebulizers
- 3.3.10.1. Insights
- 3.3.10.2. Key Takeaways
- 3.3.11. Transdermal Patches
- 3.3.11.1. Insights
- 3.3.11.2. Key Takeaways
- 3.3.12. Infusion Pumps
- 3.3.12.1. Insights
- 3.3.12.2. Key Takeaways
- 3.3.13. Others
- 3.3.13.1. Insights
- 3.3.13.2. Key Takeaways
- 3.3.1. Inhalers
- 3.4. Global Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 3.5. Global Drug Delivery Devices Market Attractiveness Analysis, By Application
- 3.5.1. Oncology
- 3.5.1.1. Insights
- 3.5.1.2. Key Takeaways
- 3.5.2. Infectious Diseases
- 3.5.2.1. Insights
- 3.5.2.2. Key Takeaways
- 3.5.3. Respiratory Diseases
- 3.5.3.1. Insights
- 3.5.3.2. Key Takeaways
- 3.5.4. Diabetes
- 3.5.4.1. Insights
- 3.5.4.2. Key Takeaways
- 3.5.5. Cardiovascular Diseases
- 3.5.5.1. Insights
- 3.5.5.2. Key Takeaways
- 3.5.6. Autoimmune Diseases
- 3.5.6.1. Insights
- 3.5.6.2. Key Takeaways
- 3.5.7. Central Nervous System Disorders
- 3.5.7.1. Insights
- 3.5.7.2. Key Takeaways
- 3.5.8. Others
- 3.5.8.1. Insights
- 3.5.8.2. Key Takeaways
- 3.5.1. Oncology
- 3.6. Global Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2020-2034
- 3.7. Global Drug Delivery Devices Market Attractiveness Analysis, By End User
- 3.7.1. Hospitals
- 3.7.1.1. Insights
- 3.7.1.2. Key Takeaways
- 3.7.2. Diagnostic Centers
- 3.7.2.1. Insights
- 3.7.2.2. Key Takeaways
- 3.7.3. Ambulatory Surgery Centers/Clinics
- 3.7.3.1. Insights
- 3.7.3.2. Key Takeaways
- 3.7.4. Home Care Settings
- 3.7.4.1. Insights
- 3.7.4.2. Key Takeaways
- 3.7.5. Others
- 3.7.5.1. Insights
- 3.7.5.2. Key Takeaways
- 3.7.1. Hospitals
- 4. Global Drug Delivery Devices Market Analysis and Forecast, By Region, 2020-2034
- 4.1. Key Findings
- 4.2. Global Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
- 4.2.1. North America
- 4.2.1.1. Regional Insights
- 4.2.2. Europe
- 4.2.2.1. Regional Insights
- 4.2.3. Asia Pacific
- 4.2.3.1. Regional Insights
- 4.2.4. Latin America
- 4.2.4.1. Regional Insights
- 4.2.5. Middle East & Africa
- 4.2.5.1. Regional Insights
- 4.2.1. North America
- 4.3. Global Drug Delivery Devices Market Attractiveness Analysis, By Region
- 5. North America Drug Delivery Devices Market Analysis and Forecast, 2020-2034
- 5.1. Key Findings
- 5.2. North America Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
- 5.3. North America Drug Delivery Devices Market Attractiveness Analysis, By Product
- 5.4. North America Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 5.5. North America Drug Delivery Devices Market Attractiveness Analysis, By Application
- 5.6. North America Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2020-2034
- 5.7. North America Drug Delivery Devices Market Attractiveness Analysis, By End User
- 5.8. North America Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 5.9. North America Drug Delivery Devices Market Attractiveness Analysis, By Country
- 5.9.1. The US
- 5.9.2. Canada
- 6. Europe Drug Delivery Devices Market Analysis and Forecast, 2020-2034
- 6.1. Key Findings
- 6.2. Europe Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
- 6.3. Europe Drug Delivery Devices Market Attractiveness Analysis, By Product
- 6.4. Europe Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 6.5. Europe Drug Delivery Devices Market Attractiveness Analysis, By Application
- 6.6. Europe Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2020-2034
- 6.7. Europe Drug Delivery Devices Market Attractiveness Analysis, By End User
- 6.8. Europe Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 6.9. Europe Drug Delivery Devices Market Attractiveness Analysis, By Country
- 6.9.1. Germany
- 6.9.2. The UK
- 6.9.3. France
- 6.9.4. Spain
- 6.9.5. Italy
- 6.9.6. Russia
- 6.9.7. Netherland
- 6.9.8. Rest of Europe
- 7. Asia Pacific Drug Delivery Devices Market Analysis and Forecast, 2020-2034
- 7.1. Key Findings
- 7.2. Asia Pacific Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
- 7.3. Asia Pacific Drug Delivery Devices Market Attractiveness Analysis, By Product
- 7.4. Asia Pacific Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 7.5. Asia Pacific Drug Delivery Devices Market Attractiveness Analysis, By Application
- 7.6. Asia Pacific Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2020-2034
- 7.7. Asia Pacific Drug Delivery Devices Market Attractiveness Analysis, By End User
- 7.8. Asia Pacific Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 7.9. Asia Pacific Drug Delivery Devices Market Attractiveness Analysis, By Country
- 7.9.1. China
- 7.9.2. Japan
- 7.9.3. South Korea
- 7.9.4. India
- 7.9.5. Australia
- 7.9.6. New Zealand
- 7.9.7. Singapore
- 7.9.8. Thailand
- 7.9.9. Vietnam
- 7.9.10. Rest of Asia Pacific
- 8. Latin America Drug Delivery Devices Market Analysis and Forecast, 2020-2034
- 8.1. Key Findings
- 8.2. Latin America Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
- 8.3. Latin America Drug Delivery Devices Market Attractiveness Analysis, By Product
- 8.4. Latin America Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 8.5. Latin America Drug Delivery Devices Market Attractiveness Analysis, By Application
- 8.6. Latin America Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2020-2034
- 8.7. Latin America Drug Delivery Devices Market Attractiveness Analysis, By End User
- 8.8. Latin America Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 8.9. Latin America Drug Delivery Devices Market Attractiveness Analysis, By Country
- 8.9.1. Brazil
- 8.9.2. Mexico
- 8.9.3. Rest of Latin America
- 9. Middle East & Africa Drug Delivery Devices Market Analysis and Forecast, 2020-2034
- 9.1. Key Findings
- 9.2. Middle East & Africa Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
- 9.3. Middle East & Africa Drug Delivery Devices Market Attractiveness Analysis, By Product
- 9.4. Middle East & Africa Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 9.5. Middle East & Africa Drug Delivery Devices Market Attractiveness Analysis, By Application
- 9.6. Middle East & Africa Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2020-2034
- 9.7. Middle East & Africa Drug Delivery Devices Market Attractiveness Analysis, By End User
- 9.8. Middle East & Africa Drug Delivery Devices Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 9.9. Middle East & Africa Drug Delivery Devices Market Attractiveness Analysis, By Country
- 9.9.1. South Africa
- 9.9.2. Saudi Arabia
- 9.9.3. UAE
- 9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
- 10.1. Market Competition Scenario Analysis, By Company
- 10.1.1. Key Takeaways
- 10.2. Overview of Major Market Players
- 10.3. Competitor Landscape
- 10.4. Strategic Mapping
- 10.5. Company Life Cycle Analysis
- 10.6. Company Market Share Analysis
- 10.7. Company Profiles
- 10.7.1. Medtronic
- 10.7.1.1. Company Details
- 10.7.1.2. Business Overview
- 10.7.1.3. Product Portfolio
- 10.7.1.4. Financial Insights
- 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.1.6. SWOT Analysis
- 10.7.1.7. Geographic Footprint
- 10.7.2. Johnson & Johnson
- 10.7.2.1. Company Details
- 10.7.2.2. Business Overview
- 10.7.2.3. Product Portfolio
- 10.7.2.4. Financial Insights
- 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.2.6. SWOT Analysis
- 10.7.2.7. Geographic Footprint
- 10.7.3. Novartis
- 10.7.3.1. Company Details
- 10.7.3.2. Business Overview
- 10.7.3.3. Product Portfolio
- 10.7.3.4. Financial Insights
- 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.3.6. SWOT Analysis
- 10.7.3.7. Geographic Footprint
- 10.7.4. Becton, Dickinson and Company (BD)
-
- 10.7.4.1. Company Details
- 10.7.4.2. Business Overview
- 10.7.4.3. Product Portfolio
- 10.7.4.4. Financial Insights
- 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.4.6. SWOT Analysis
- 10.7.4.7. Geographic Footprint
- 10.7.5. Mylan N.V.
- 10.7.5.1. Company Details
- 10.7.5.2. Business Overview
- 10.7.5.3. Product Portfolio
- 10.7.5.4. Financial Insights
- 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.5.6. SWOT Analysis
- 10.7.5.7. Geographic Footprint
-
- 10.7.6. Baxter International Inc.
- 10.7.6.1. Company Details
- 10.7.6.2. Business Overview
- 10.7.6.3. Product Portfolio
- 10.7.6.4. Financial Insights
- 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.6.6. SWOT Analysis
- 10.7.6.7. Geographic Footprint
- 10.7.7. 3M Health Care
- 10.7.7.1. Company Details
- 10.7.7.2. Business Overview
- 10.7.7.3. Product Portfolio
- 10.7.7.4. Financial Insights
- 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.7.6. SWOT Analysis
- 10.7.7.7. Geographic Footprint
- 10.7.8. Gerresheimer AG
- 10.7.8.1. Company Details
- 10.7.8.2. Business Overview
- 10.7.8.3. Product Portfolio
- 10.7.8.4. Financial Insights
- 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.8.6. SWOT Analysis
- 10.7.8.7. Geographic Footprint
- 10.7.9. Sandoz (a Novartis division)
- 10.7.9.1. Company Details
- 10.7.9.2. Business Overview
- 10.7.9.3. Product Portfolio
- 10.7.9.4. Financial Insights
- 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.9.6. SWOT Analysis
- 10.7.9.7. Geographic Footprint
- 10.7.10. Bayer AG
- 10.7.10.1. Company Details
- 10.7.10.2. Business Overview
- 10.7.10.3. Product Portfolio
- 10.7.10.4. Financial Insights
- 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.10.6. SWOT Analysis
- 10.7.10.7. Geographic Footprint
- 10.7.11. GlaxoSmithKline
- 10.7.11.1. Company Details
- 10.7.11.2. Business Overview
- 10.7.11.3. Product Portfolio
- 10.7.11.4. Financial Insights
- 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.11.6. SWOT Analysis
- 10.7.11.7. Geographic Footprint
- 10.7.12. Eli Lilly and Company
- 10.7.12.1. Company Details
- 10.7.12.2. Business Overview
- 10.7.12.3. Product Portfolio
- 10.7.12.4. Financial Insights
- 10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.12.6. SWOT Analysis
- 10.7.12.7. Geographic Footprint
- 10.7.1. Medtronic
- 10.1. Market Competition Scenario Analysis, By Company
- 11. Methodology and Data Source
- 11.1. Methodology/Research Approach
- 11.2. Market Size Estimation
- 11.3. Market Breakdown and Data Triangulation
- 11.4. Data Source
- 11.5. Secondary Sources
- 11.6. Primary Sources
- 11.7. Appendix
- 11.8. Disclaimer
List of Tables
- Table 1. Global Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 2. Global Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 3. Global Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 4. Global Drug Delivery Devices Market Value (US$ Mn), By Region, 2020-2034
- Table 5. North America Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 6. North America Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 7. North America Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 8. North America Drug Delivery Devices Market Value (US$ Mn), By Country, 2020-2034
- Table 9. The US Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 10. The US Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 11. The US Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 12. Canada Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 13. Canada Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 14. Canada Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 15. Europe Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 16. Europe Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 17. Europe Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 18. Europe Drug Delivery Devices Market Value (US$ Mn), By Country, 2020-2034
- Table 19. Germany Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 20. Germany Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 21. Germany Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 22. The UK Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 23. The UK Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 24. The UK Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 25. France Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 26. France Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 27. France Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 28. Spain Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 29. Spain Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 30. Spain Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 31. Italy Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 32. Italy Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 33. Italy Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 34. Russia Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 35. Russia Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 36. Russia Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 37. Netherland Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 38. Netherland Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 39. Netherland Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 40. Rest of Europe Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 41. Rest of Europe Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 42. Rest of Europe Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 43. Asia Pacific Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 44. Asia Pacific Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 45. Asia Pacific Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 46. Asia Pacific Drug Delivery Devices Market Value (US$ Mn), By Country, 2020-2034
- Table 47. China Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 48. China Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 49. China Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 50. India Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 51. India Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 52. India Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 53. Japan Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 54. Japan Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 55. Japan Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 56. South Korea Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 57. South Korea Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 58. South Korea Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 59. Australia Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 60. Australia Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 61. Australia Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 62. New Zealand Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 63. New Zealand Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 64. New Zealand Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 65. Singapore Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 66. Singapore Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 67. Singapore Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 68. Thailand Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 69. Thailand Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 70. Thailand Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 71. Vietnam Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 72. Vietnam Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 73. Vietnam Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 74. Rest of Asia Pacific Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 75. Rest of Asia Pacific Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 76. Rest of Asia Pacific Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 77. Latin America Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 78. Latin America Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 79. Latin America Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 80. Latin America Drug Delivery Devices Market Value (US$ Mn), By Country, 2020-2034
- Table 81. Brazil Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 82. Brazil Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 83. Brazil Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 84. Mexico Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 85. Mexico Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 86. Mexico Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 87. Rest of Latin America Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 88. Rest of Latin America Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 89. Rest of Latin America Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 90. Middle East & Africa Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 91. Middle East & Africa Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 92. Middle East & Africa Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 93. Middle East & Africa Drug Delivery Devices Market Value (US$ Mn), By Country, 2020-2034
- Table 94. South Africa Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 95. South Africa Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 96. South Africa Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 97. Saudi Arabia Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 98. Saudi Arabia Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 99. Saudi Arabia Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 100. UAE Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 101. UAE Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 102. UAE Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
- Table 103. Rest of Middle East & Africa Drug Delivery Devices Market Value (US$ Mn), By Product, 2020-2034
- Table 104. Rest of Middle East & Africa Drug Delivery Devices Market Value (US$ Mn), By Application, 2020-2034
- Table 105. Rest of Middle East & Africa Drug Delivery Devices Market Value (US$ Mn), By End User, 2020-2034
List of Figures
- Figure 1. Global Drug Delivery Devices Market Snapshot: Market Value (US$ Mn), 2020-2034
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Drug Delivery Devices Market
- Figure 5. Global Drug Delivery Devices Market Analysis, By Product, 2020, 2024 and 2034
- Figure 6. Global Drug Delivery Devices Market Attractiveness Analysis, By Product
- Figure 7. Global Drug Delivery Devices Market Analysis, By Application, 2020, 2024 and 2034
- Figure 8. Global Drug Delivery Devices Market Attractiveness Analysis, By Application
- Figure 9. Global Drug Delivery Devices Market Analysis, By End User, 2020, 2024 and 2034
- Figure 10. Global Drug Delivery Devices Market Attractiveness Analysis, By End User
- Figure 11. Global Drug Delivery Devices Market Analysis, By Region, 2020, 2024 and 2034
- Figure 12. Global Drug Delivery Devices Market Attractiveness Analysis, By Region
- Figure 13. North America Drug Delivery Devices Market Analysis, By Product, 2020, 2024 and 2034
- Figure 14. North America Drug Delivery Devices Market Attractiveness Analysis, By Product
- Figure 15. North America Drug Delivery Devices Market (US$ Mn), by Inhalers, 2020-2034
- Figure 16. North America Drug Delivery Devices Market (US$ Mn), by Injection Devices, 2020-2034
- Figure 17. North America Drug Delivery Devices Market (US$ Mn), by Implants, 2020-2034
- Figure 18. North America Drug Delivery Devices Market (US$ Mn), by Contraceptive implants, 2020-2034
- Figure 19. North America Drug Delivery Devices Market (US$ Mn), by Drug-eluting stents, 2020-2034
- Figure 20. North America Drug Delivery Devices Market (US$ Mn), by Biodegradable implants, 2020-2034
- Figure 21. North America Drug Delivery Devices Market (US$ Mn), by Topical Delivery System, 2020-2034
- Figure 22. North America Drug Delivery Devices Market (US$ Mn), by Oral Delivery System, 2020-2034
- Figure 23. North America Drug Delivery Devices Market (US$ Mn), by Occular Delivery System, 2020-2034
- Figure 24. North America Drug Delivery Devices Market Analysis, By Application, 2020, 2024 and 2034
- Figure 25. North America Drug Delivery Devices Market Attractiveness Analysis, By Application
- Figure 26. North America Drug Delivery Devices Market (US$ Mn), by Oncology, 2020-2034
- Figure 27. North America Drug Delivery Devices Market (US$ Mn), by Infectious Diseases, 2020-2034
- Figure 28. North America Drug Delivery Devices Market (US$ Mn), by Respiratory Diseases, 2020-2034
- Figure 29. North America Drug Delivery Devices Market (US$ Mn), by Diabetes, 2020-2034
- Figure 30. North America Drug Delivery Devices Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
- Figure 31. North America Drug Delivery Devices Market (US$ Mn), by Autoimmune Diseases, 2020-2034
- Figure 32. North America Drug Delivery Devices Market (US$ Mn), by Central Nervous System Disorders, 2020-2034
- Figure 33. North America Drug Delivery Devices Market (US$ Mn), by Others, 2020-2034
- Figure 34. North America Drug Delivery Devices Market Analysis, By End User, 2020, 2024 and 2034
- Figure 35. North America Drug Delivery Devices Market Attractiveness Analysis, By End User
- Figure 36. North America Drug Delivery Devices Market (US$ Mn), by Hospitals, 2020-2034
- Figure 37. North America Drug Delivery Devices Market (US$ Mn), by Diagnostic Centers, 2020-2034
- Figure 38. North America Drug Delivery Devices Market (US$ Mn), by Ambulatory Surgery Centers/Clinics, 2020-2034
- Figure 39. North America Drug Delivery Devices Market (US$ Mn), by Home Care Settings, 2020-2034
- Figure 40. North America Drug Delivery Devices Market (US$ Mn), by Others, 2020-2034
- Figure 41. North America Drug Delivery Devices Market Analysis, By Country, 2020, 2024 and 2034
- Figure 42. North America Drug Delivery Devices Market Attractiveness Analysis, By Country
- Figure 43. Europe Drug Delivery Devices Market Analysis, By Product, 2020, 2024 and 2034
- Figure 44. Europe Drug Delivery Devices Market Attractiveness Analysis, By Product
- Figure 45. Europe Drug Delivery Devices Market (US$ Mn), by Inhalers, 2020-2034
- Figure 46. Europe Drug Delivery Devices Market (US$ Mn), by Injection Devices, 2020-2034
- Figure 47. Europe Drug Delivery Devices Market (US$ Mn), by Implants, 2020-2034
- Figure 48. Europe Drug Delivery Devices Market (US$ Mn), by Contraceptive implants, 2020-2034
- Figure 49. Europe Drug Delivery Devices Market (US$ Mn), by Drug-eluting stents, 2020-2034
- Figure 50. Europe Drug Delivery Devices Market (US$ Mn), by Biodegradable implants, 2020-2034
- Figure 51. Europe Drug Delivery Devices Market (US$ Mn), by Topical Delivery System, 2020-2034
- Figure 52. Europe Drug Delivery Devices Market (US$ Mn), by Oral Delivery System, 2020-2034
- Figure 53. Europe Drug Delivery Devices Market (US$ Mn), by Occular Delivery System, 2020-2034
- Figure 54. Europe Drug Delivery Devices Market Analysis, By Application, 2020, 2024 and 2034
- Figure 55. Europe Drug Delivery Devices Market Attractiveness Analysis, By Application
- Figure 56. Europe Drug Delivery Devices Market (US$ Mn), by Oncology, 2020-2034
- Figure 57. Europe Drug Delivery Devices Market (US$ Mn), by Infectious Diseases, 2020-2034
- Figure 58. Europe Drug Delivery Devices Market (US$ Mn), by Respiratory Diseases, 2020-2034
- Figure 59. Europe Drug Delivery Devices Market (US$ Mn), by Diabetes, 2020-2034
- Figure 60. Europe Drug Delivery Devices Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
- Figure 61. Europe Drug Delivery Devices Market (US$ Mn), by Autoimmune Diseases, 2020-2034
- Figure 62. Europe Drug Delivery Devices Market (US$ Mn), by Central Nervous System Disorders, 2020-2034
- Figure 63. Europe Drug Delivery Devices Market (US$ Mn), by Others, 2020-2034
- Figure 64. Europe Drug Delivery Devices Market Analysis, By End User, 2020, 2024 and 2034
- Figure 65. Europe Drug Delivery Devices Market Attractiveness Analysis, By End User
- Figure 66. Europe Drug Delivery Devices Market (US$ Mn), by Hospitals, 2020-2034
- Figure 67. Europe Drug Delivery Devices Market (US$ Mn), by Diagnostic Centers, 2020-2034
- Figure 68. Europe Drug Delivery Devices Market (US$ Mn), by Ambulatory Surgery Centers/Clinics, 2020-2034
- Figure 69. Europe Drug Delivery Devices Market (US$ Mn), by Home Care Settings, 2020-2034
- Figure 70. Europe Drug Delivery Devices Market (US$ Mn), by Others, 2020-2034
- Figure 71. Europe Drug Delivery Devices Market Analysis, By Country, 2020, 2024 and 2034
- Figure 72. Europe Drug Delivery Devices Market Attractiveness Analysis, By Country
- Figure 73. Asia Pacific Drug Delivery Devices Market Analysis, By Product, 2020, 2024 and 2034
- Figure 74. Asia Pacific Drug Delivery Devices Market Attractiveness Analysis, By Product
- Figure 75. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Inhalers, 2020-2034
- Figure 76. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Injection Devices, 2020-2034
- Figure 77. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Implants, 2020-2034
- Figure 78. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Contraceptive implants, 2020-2034
- Figure 79. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Drug-eluting stents, 2020-2034
- Figure 80. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Biodegradable implants, 2020-2034
- Figure 81. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Topical Delivery System, 2020-2034
- Figure 82. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Oral Delivery System, 2020-2034
- Figure 83. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Occular Delivery System, 2020-2034
- Figure 84. Asia Pacific Drug Delivery Devices Market Analysis, By Application, 2020, 2024 and 2034
- Figure 85. Asia Pacific Drug Delivery Devices Market Attractiveness Analysis, By Application
- Figure 86. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Oncology, 2020-2034
- Figure 87. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Infectious Diseases, 2020-2034
- Figure 88. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Respiratory Diseases, 2020-2034
- Figure 89. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Diabetes, 2020-2034
- Figure 90. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
- Figure 91. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Autoimmune Diseases, 2020-2034
- Figure 92. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Central Nervous System Disorders, 2020-2034
- Figure 93. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Others, 2020-2034
- Figure 94. Asia Pacific Drug Delivery Devices Market Analysis, By End User, 2020, 2024 and 2034
- Figure 95. Asia Pacific Drug Delivery Devices Market Attractiveness Analysis, By End User
- Figure 96. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Hospitals, 2020-2034
- Figure 97. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Diagnostic Centers, 2020-2034
- Figure 98. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Ambulatory Surgery Centers/Clinics, 2020-2034
- Figure 99. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Home Care Settings, 2020-2034
- Figure 100. Asia Pacific Drug Delivery Devices Market (US$ Mn), by Others, 2020-2034
- Figure 101. Asia Pacific Drug Delivery Devices Market Analysis, By Country, 2020, 2024 and 2034
- Figure 102. Asia Pacific Drug Delivery Devices Market Attractiveness Analysis, By Country
- Figure 103. Latin America Drug Delivery Devices Market Analysis, By Product, 2020, 2024 and 2034
- Figure 104. Latin America Drug Delivery Devices Market Attractiveness Analysis, By Product
- Figure 105. Latin America Drug Delivery Devices Market (US$ Mn), by Inhalers, 2020-2034
- Figure 106. Latin America Drug Delivery Devices Market (US$ Mn), by Injection Devices, 2020-2034
- Figure 107. Latin America Drug Delivery Devices Market (US$ Mn), by Implants, 2020-2034
- Figure 108. Latin America Drug Delivery Devices Market (US$ Mn), by Contraceptive implants, 2020-2034
- Figure 109. Latin America Drug Delivery Devices Market (US$ Mn), by Drug-eluting stents, 2020-2034
- Figure 110. Latin America Drug Delivery Devices Market (US$ Mn), by Biodegradable implants, 2020-2034
- Figure 111. Latin America Drug Delivery Devices Market (US$ Mn), by Topical Delivery System, 2020-2034
- Figure 112. Latin America Drug Delivery Devices Market (US$ Mn), by Oral Delivery System, 2020-2034
- Figure 113. Latin America Drug Delivery Devices Market (US$ Mn), by Occular Delivery System, 2020-2034
- Figure 114. Latin America Drug Delivery Devices Market Analysis, By Application, 2020, 2024 and 2034
- Figure 115. Latin America Drug Delivery Devices Market Attractiveness Analysis, By Application
- Figure 116. Latin America Drug Delivery Devices Market (US$ Mn), by Oncology, 2020-2034
- Figure 117. Latin America Drug Delivery Devices Market (US$ Mn), by Infectious Diseases, 2020-2034
- Figure 118. Latin America Drug Delivery Devices Market (US$ Mn), by Respiratory Diseases, 2020-2034
- Figure 119. Latin America Drug Delivery Devices Market (US$ Mn), by Diabetes, 2020-2034
- Figure 120. Latin America Drug Delivery Devices Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
- Figure 121. Latin America Drug Delivery Devices Market (US$ Mn), by Autoimmune Diseases, 2020-2034
- Figure 122. Latin America Drug Delivery Devices Market (US$ Mn), by Central Nervous System Disorders, 2020-2034
- Figure 123. Latin America Drug Delivery Devices Market (US$ Mn), by Others, 2020-2034
- Figure 124. Latin America Drug Delivery Devices Market Analysis, By End User, 2020, 2024 and 2034
- Figure 125. Latin America Drug Delivery Devices Market Attractiveness Analysis, By End User
- Figure 126. Latin America Drug Delivery Devices Market (US$ Mn), by Hospitals, 2020-2034
- Figure 127. Latin America Drug Delivery Devices Market (US$ Mn), by Diagnostic Centers, 2020-2034
- Figure 128. Latin America Drug Delivery Devices Market (US$ Mn), by Ambulatory Surgery Centers/Clinics, 2020-2034
- Figure 129. Latin America Drug Delivery Devices Market (US$ Mn), by Home Care Settings, 2020-2034
- Figure 130. Latin America Drug Delivery Devices Market (US$ Mn), by Others, 2020-2034
- Figure 131. Latin America Drug Delivery Devices Market Analysis, By Country, 2020, 2024 and 2034
- Figure 132. Latin America Drug Delivery Devices Market Attractiveness Analysis, By Country
- Figure 133. Middle East & Africa Drug Delivery Devices Market Analysis, By Product, 2020, 2024 and 2034
- Figure 134. Middle East & Africa Drug Delivery Devices Market Attractiveness Analysis, By Product
- Figure 135. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Inhalers, 2020-2034
- Figure 136. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Injection Devices, 2020-2034
- Figure 137. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Implants, 2020-2034
- Figure 138. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Contraceptive implants, 2020-2034
- Figure 139. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Drug-eluting stents, 2020-2034
- Figure 140. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Biodegradable implants, 2020-2034
- Figure 141. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Topical Delivery System, 2020-2034
- Figure 142. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Oral Delivery System, 2020-2034
- Figure 143. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Occular Delivery System, 2020-2034
- Figure 144. Middle East & Africa Drug Delivery Devices Market Analysis, By Application, 2020, 2024 and 2034
- Figure 145. Middle East & Africa Drug Delivery Devices Market Attractiveness Analysis, By Application
- Figure 146. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Oncology, 2020-2034
- Figure 147. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Infectious Diseases, 2020-2034
- Figure 148. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Respiratory Diseases, 2020-2034
- Figure 149. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Diabetes, 2020-2034
- Figure 150. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
- Figure 151. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Autoimmune Diseases, 2020-2034
- Figure 152. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Central Nervous System Disorders, 2020-2034
- Figure 153. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Others, 2020-2034
- Figure 154. Middle East & Africa Drug Delivery Devices Market Analysis, By End User, 2020, 2024 and 2034
- Figure 155. Middle East & Africa Drug Delivery Devices Market Attractiveness Analysis, By End User
- Figure 156. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Hospitals, 2020-2034
- Figure 157. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Diagnostic Centers, 2020-2034
- Figure 158. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Ambulatory Surgery Centers/Clinics, 2020-2034
- Figure 159. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Home Care Settings, 2020-2034
- Figure 160. Middle East & Africa Drug Delivery Devices Market (US$ Mn), by Others, 2020-2034
- Figure 161. Middle East & Africa Drug Delivery Devices Market Analysis, By Country, 2020, 2024 and 2034
- Figure 162. Middle East & Africa Drug Delivery Devices Market Attractiveness Analysis, By Country
- 1. Executive Summary
-
- Medtronic
- Johnson & Johnson
- Novartis AG Company Profile
- Becton, Dickinson and Company (BD)
- Mylan N.V.
- Baxter International Inc.
- 3M Health Care
- Gerresheimer AG Company Profile
- Sandoz (a Novartis division)
- Bayer AG Company Profile
- GlaxoSmithKline
- Eli Lilly and Company
- Others
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible